In Situ Hybridization (ISH)
In Situ Hybridization (ISH) is a technique that allows for precise localization of a specific segment of nucleic acid within a histologic section.
The underlying basis of ISH is that nucleic acids, if preserved adequately within a histologic specimen, can be detected through the application of a complementary strand of nucleic acid to which a reporter molecule is attached.
Visualization of the reporter molecule allows to localize DNA or RNA sequences in a heterogeneous cell populations including tissue samples and environmental samples. Riboprobes also allow to localize and assess degree of
In Situ Hybridization (ISH) is a technique that allows for precise localization of a specific segment of nucleic acid within a histologic section.
The underlying basis of ISH is that nucleic acids, if preserved adequately within a histologic specimen, can be detected through the application of a complementary strand of nucleic acid to which a reporter molecule is attached.
Visualization of the reporter molecule allows to localize DNA or RNA sequences in a heterogeneous cell populations including tissue samples and environmental samples. Riboprobes also allow to localize and assess degree of
Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Major Manufacturers Covered in This Report
1.3 Market Segment by Type
1.3.1 Global In-Situ Hybridization Market Size Growth Rate by Type (2019-2025)
1.3.2 Radioactive isotopes
1.3.3 Non-radioactive labels
1.4 Market Segment by Application
1.4.1 Global In-Situ Hybridization Market Share by Application (2019-2025)
1.4.2 Cancer Diagnosis
1.4.3 Immunology
1.4.4 Neuroscience
1.4.5 Cytology
1.4.6 Infectious Diseases
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global In-Situ Hybridization Market Size
2.1.1 Global In-Situ Hybridization Revenue 2014-2025
2.1.2 Global In-Situ Hybridization Sales 2014-2025
2.2 In-Situ Hybridization Growth Rate by Regions
2.2.1 Global In-Situ Hybridization Sales by Regions 2014-2019
2.2.2 Global In-Situ Hybridization Revenue by Regions 2014-2019
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
3 Market Share by Manufacturers
3.1 In-Situ Hybridization Sales by Manufacturers
3.1.1 In-Situ Hybridization Sales by Manufacturers 2014-2019
3.1.2 In-Situ Hybridization Sales Market Share by Manufacturers 2014-2019
3.2 Revenue by Manufacturers
3.2.1 In-Situ Hybridization Revenue by Manufacturers (2014-2019)
3.2.2 In-Situ Hybridization Revenue Share by Manufacturers (2014-2019)
3.2.3 Global In-Situ Hybridization Market Concentration Ratio (CR5 and HHI)
3.3 In-Situ Hybridization Price by Manufacturers
3.4 Key Manufacturers In-Situ Hybridization Plants/Factories Distribution and Area Served
3.5 Date of Key Manufacturers Enter into In-Situ Hybridization Market
3.6 Key Manufacturers In-Situ Hybridization Product Offered
3.7 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Sales and Revenue for Each Type
4.1.1 Radioactive isotopes Sales and Revenue (2014-2019)
4.1.2 Non-radioactive labels Sales and Revenue (2014-2019)
4.2 Global In-Situ Hybridization Sales Market Share by Type
4.3 Global In-Situ Hybridization Revenue Market Share by Type
4.4 In-Situ Hybridization Price by Type
5 Market Size by Application
5.1 Overview
5.2 Global In-Situ Hybridization Sales by Application
6 United States
6.1 United States In-Situ Hybridization Breakdown Data by Company
6.2 United States In-Situ Hybridization Breakdown Data by Type
6.3 United States In-Situ Hybridization Breakdown Data by Application
7 European Union
7.1 European Union In-Situ Hybridization Breakdown Data by Company
7.2 European Union In-Situ Hybridization Breakdown Data by Type
7.3 European Union In-Situ Hybridization Breakdown Data by Application
8 China
8.1 China In-Situ Hybridization Breakdown Data by Company
8.2 China In-Situ Hybridization Breakdown Data by Type
8.3 China In-Situ Hybridization Breakdown Data by Application
9 Rest of World
9.1 Rest of World In-Situ Hybridization Breakdown Data by Company
9.2 Rest of World In-Situ Hybridization Breakdown Data by Type
9.3 Rest of World In-Situ Hybridization Breakdown Data by Application
9.4 Rest of World In-Situ Hybridization Breakdown Data by Countries
9.4.1 Rest of World In-Situ Hybridization Sales by Countries
9.4.2 Rest of World In-Situ Hybridization Revenue by Countries
9.4.3 Japan
9.4.4 Korea
9.4.5 India
9.4.6 Southeast Asia
10 Company Profiles
10.1 Abbott Laboratories
10.1.1 Abbott Laboratories Company Details
10.1.2 Company Description and Business Overview
10.1.3 Sales, Revenue and Market Share of In-Situ Hybridization
10.1.4 In-Situ Hybridization Product Introduction
10.1.5 Abbott Laboratories Recent Development
10.2 F. Hoffmann-La Roche
10.2.1 F. Hoffmann-La Roche Company Details
10.2.2 Company Description and Business Overview
10.2.3 Sales, Revenue and Market Share of In-Situ Hybridization
10.2.4 In-Situ Hybridization Product Introduction
10.2.5 F. Hoffmann-La Roche Recent Development
10.3 Leica Biosystems Nussloch
10.3.1 Leica Biosystems Nussloch Company Details
10.3.2 Company Description and Business Overview
10.3.3 Sales, Revenue and Market Share of In-Situ Hybridization
10.3.4 In-Situ Hybridization Product Introduction
10.3.5 Leica Biosystems Nussloch Recent Development
10.4 Agilent Technologies
10.4.1 Agilent Technologies Company Details
10.4.2 Company Description and Business Overview
10.4.3 Sales, Revenue and Market Share of In-Situ Hybridization
10.4.4 In-Situ Hybridization Product Introduction
10.4.5 Agilent Technologies Recent Development
10.5 Thermo Fisher Scientific
10.5.1 Thermo Fisher Scientific Company Details
10.5.2 Company Description and Business Overview
10.5.3 Sales, Revenue and Market Share of In-Situ Hybridization
10.5.4 In-Situ Hybridization Product Introduction
10.5.5 Thermo Fisher Scientific Recent Development
10.6 Merck
10.6.1 Merck Company Details
10.6.2 Company Description and Business Overview
10.6.3 Sales, Revenue and Market Share of In-Situ Hybridization
10.6.4 In-Situ Hybridization Product Introduction
10.6.5 Merck Recent Development
10.7 PerkinElmer
10.7.1 PerkinElmer Company Details
10.7.2 Company Description and Business Overview
10.7.3 Sales, Revenue and Market Share of In-Situ Hybridization
10.7.4 In-Situ Hybridization Product Introduction
10.7.5 PerkinElmer Recent Development
10.8 Exiqon A/S
10.8.1 Exiqon A/S Company Details
10.8.2 Company Description and Business Overview
10.8.3 Sales, Revenue and Market Share of In-Situ Hybridization
10.8.4 In-Situ Hybridization Product Introduction
10.8.5 Exiqon A/S Recent Development
10.9 BioGenex Laboratories
10.9.1 BioGenex Laboratories Company Details
10.9.2 Company Description and Business Overview
10.9.3 Sales, Revenue and Market Share of In-Situ Hybridization
10.9.4 In-Situ Hybridization Product Introduction
10.9.5 BioGenex Laboratories Recent Development
10.10 Advanced Cell Diagnostics
10.10.1 Advanced Cell Diagnostics Company Details
10.10.2 Company Description and Business Overview
10.10.3 Sales, Revenue and Market Share of In-Situ Hybridization
10.10.4 In-Situ Hybridization Product Introduction
10.10.5 Advanced Cell Diagnostics Recent Development
10.11 Bio SB
11 Value Chain and Sales Channels Analysis
11.1 Value Chain Analysis
11.2 Sales Channels Analysis
11.2.1 In-Situ Hybridization Sales Channels
11.2.2 In-Situ Hybridization Distributors
11.3 In-Situ Hybridization Customers
12 Market Forecast
12.1 Global In-Situ Hybridization Sales and Revenue Forecast 2019-2025
12.2 Global In-Situ Hybridization Sales Forecast by Type
12.3 Global In-Situ Hybridization Sales Forecast by Application
12.4 In-Situ Hybridization Forecast by Regions
12.4.1 Global In-Situ Hybridization Sales Forecast by Regions 2019-2025
12.4.2 Global In-Situ Hybridization Revenue Forecast by Regions 2019-2025
12.5 United States Market Forecast
12.6 European Union Market Forecast
12.7 China Market Forecast
12.8 Rest of World
12.8.1 Japan
12.8.2 Korea
12.8.3 India
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer
1 Report Overview
1.1 Study Scope
1.2 Major Manufacturers Covered in This Report
1.3 Market Segment by Type
1.3.1 Global In-Situ Hybridization Market Size Growth Rate by Type (2019-2025)
1.3.2 Radioactive isotopes
1.3.3 Non-radioactive labels
1.4 Market Segment by Application
1.4.1 Global In-Situ Hybridization Market Share by Application (2019-2025)
1.4.2 Cancer Diagnosis
1.4.3 Immunology
1.4.4 Neuroscience
1.4.5 Cytology
1.4.6 Infectious Diseases
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global In-Situ Hybridization Market Size
2.1.1 Global In-Situ Hybridization Revenue 2014-2025
2.1.2 Global In-Situ Hybridization Sales 2014-2025
2.2 In-Situ Hybridization Growth Rate by Regions
2.2.1 Global In-Situ Hybridization Sales by Regions 2014-2019
2.2.2 Global In-Situ Hybridization Revenue by Regions 2014-2019
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
3 Market Share by Manufacturers
3.1 In-Situ Hybridization Sales by Manufacturers
3.1.1 In-Situ Hybridization Sales by Manufacturers 2014-2019
3.1.2 In-Situ Hybridization Sales Market Share by Manufacturers 2014-2019
3.2 Revenue by Manufacturers
3.2.1 In-Situ Hybridization Revenue by Manufacturers (2014-2019)
3.2.2 In-Situ Hybridization Revenue Share by Manufacturers (2014-2019)
3.2.3 Global In-Situ Hybridization Market Concentration Ratio (CR5 and HHI)
3.3 In-Situ Hybridization Price by Manufacturers
3.4 Key Manufacturers In-Situ Hybridization Plants/Factories Distribution and Area Served
3.5 Date of Key Manufacturers Enter into In-Situ Hybridization Market
3.6 Key Manufacturers In-Situ Hybridization Product Offered
3.7 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Sales and Revenue for Each Type
4.1.1 Radioactive isotopes Sales and Revenue (2014-2019)
4.1.2 Non-radioactive labels Sales and Revenue (2014-2019)
4.2 Global In-Situ Hybridization Sales Market Share by Type
4.3 Global In-Situ Hybridization Revenue Market Share by Type
4.4 In-Situ Hybridization Price by Type
5 Market Size by Application
5.1 Overview
5.2 Global In-Situ Hybridization Sales by Application
6 United States
6.1 United States In-Situ Hybridization Breakdown Data by Company
6.2 United States In-Situ Hybridization Breakdown Data by Type
6.3 United States In-Situ Hybridization Breakdown Data by Application
7 European Union
7.1 European Union In-Situ Hybridization Breakdown Data by Company
7.2 European Union In-Situ Hybridization Breakdown Data by Type
7.3 European Union In-Situ Hybridization Breakdown Data by Application
8 China
8.1 China In-Situ Hybridization Breakdown Data by Company
8.2 China In-Situ Hybridization Breakdown Data by Type
8.3 China In-Situ Hybridization Breakdown Data by Application
9 Rest of World
9.1 Rest of World In-Situ Hybridization Breakdown Data by Company
9.2 Rest of World In-Situ Hybridization Breakdown Data by Type
9.3 Rest of World In-Situ Hybridization Breakdown Data by Application
9.4 Rest of World In-Situ Hybridization Breakdown Data by Countries
9.4.1 Rest of World In-Situ Hybridization Sales by Countries
9.4.2 Rest of World In-Situ Hybridization Revenue by Countries
9.4.3 Japan
9.4.4 Korea
9.4.5 India
9.4.6 Southeast Asia
10 Company Profiles
10.1 Abbott Laboratories
10.1.1 Abbott Laboratories Company Details
10.1.2 Company Description and Business Overview
10.1.3 Sales, Revenue and Market Share of In-Situ Hybridization
10.1.4 In-Situ Hybridization Product Introduction
10.1.5 Abbott Laboratories Recent Development
10.2 F. Hoffmann-La Roche
10.2.1 F. Hoffmann-La Roche Company Details
10.2.2 Company Description and Business Overview
10.2.3 Sales, Revenue and Market Share of In-Situ Hybridization
10.2.4 In-Situ Hybridization Product Introduction
10.2.5 F. Hoffmann-La Roche Recent Development
10.3 Leica Biosystems Nussloch
10.3.1 Leica Biosystems Nussloch Company Details
10.3.2 Company Description and Business Overview
10.3.3 Sales, Revenue and Market Share of In-Situ Hybridization
10.3.4 In-Situ Hybridization Product Introduction
10.3.5 Leica Biosystems Nussloch Recent Development
10.4 Agilent Technologies
10.4.1 Agilent Technologies Company Details
10.4.2 Company Description and Business Overview
10.4.3 Sales, Revenue and Market Share of In-Situ Hybridization
10.4.4 In-Situ Hybridization Product Introduction
10.4.5 Agilent Technologies Recent Development
10.5 Thermo Fisher Scientific
10.5.1 Thermo Fisher Scientific Company Details
10.5.2 Company Description and Business Overview
10.5.3 Sales, Revenue and Market Share of In-Situ Hybridization
10.5.4 In-Situ Hybridization Product Introduction
10.5.5 Thermo Fisher Scientific Recent Development
10.6 Merck
10.6.1 Merck Company Details
10.6.2 Company Description and Business Overview
10.6.3 Sales, Revenue and Market Share of In-Situ Hybridization
10.6.4 In-Situ Hybridization Product Introduction
10.6.5 Merck Recent Development
10.7 PerkinElmer
10.7.1 PerkinElmer Company Details
10.7.2 Company Description and Business Overview
10.7.3 Sales, Revenue and Market Share of In-Situ Hybridization
10.7.4 In-Situ Hybridization Product Introduction
10.7.5 PerkinElmer Recent Development
10.8 Exiqon A/S
10.8.1 Exiqon A/S Company Details
10.8.2 Company Description and Business Overview
10.8.3 Sales, Revenue and Market Share of In-Situ Hybridization
10.8.4 In-Situ Hybridization Product Introduction
10.8.5 Exiqon A/S Recent Development
10.9 BioGenex Laboratories
10.9.1 BioGenex Laboratories Company Details
10.9.2 Company Description and Business Overview
10.9.3 Sales, Revenue and Market Share of In-Situ Hybridization
10.9.4 In-Situ Hybridization Product Introduction
10.9.5 BioGenex Laboratories Recent Development
10.10 Advanced Cell Diagnostics
10.10.1 Advanced Cell Diagnostics Company Details
10.10.2 Company Description and Business Overview
10.10.3 Sales, Revenue and Market Share of In-Situ Hybridization
10.10.4 In-Situ Hybridization Product Introduction
10.10.5 Advanced Cell Diagnostics Recent Development
10.11 Bio SB
11 Value Chain and Sales Channels Analysis
11.1 Value Chain Analysis
11.2 Sales Channels Analysis
11.2.1 In-Situ Hybridization Sales Channels
11.2.2 In-Situ Hybridization Distributors
11.3 In-Situ Hybridization Customers
12 Market Forecast
12.1 Global In-Situ Hybridization Sales and Revenue Forecast 2019-2025
12.2 Global In-Situ Hybridization Sales Forecast by Type
12.3 Global In-Situ Hybridization Sales Forecast by Application
12.4 In-Situ Hybridization Forecast by Regions
12.4.1 Global In-Situ Hybridization Sales Forecast by Regions 2019-2025
12.4.2 Global In-Situ Hybridization Revenue Forecast by Regions 2019-2025
12.5 United States Market Forecast
12.6 European Union Market Forecast
12.7 China Market Forecast
12.8 Rest of World
12.8.1 Japan
12.8.2 Korea
12.8.3 India
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer
